Journal Summary - Discover more summaries and articles from M3 India

Allergy and Immunology

Choose Topic

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

British Journal of Dermatology | May 09, 2021 Peds Allergy/Immunology Derm Allergy/Immunology Clinical Pharmacology General Allergy/Immunology

Economic burden of patient-reported penicillin allergy prior to total hip and total knee arthroplasty

Journal of Arthroplasty | May 06, 2021 Allergy/Anaphylaxis General Allergy/Immunology

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: An open‐label study

Clinical and Experimental Dermatology | May 06, 2021 General Allergy/Immunology Clinical Pharmacology Derm Allergy/Immunology

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

The Journal of Rheumatology | May 05, 2021 Clinical Pharmacology General Allergy/Immunology Rheumatic/Autoimmune

Oral gliadin‐protected superoxide dismutase in addition to phototherapy for treating non‐segmental vitiligo: A 24‐week prospective randomized placebo‐controlled study

Journal of the European Academy of Dermatology and Venereology | May 05, 2021 Derm Allergy/Immunology General Allergy/Immunology

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients

Annals of Rheumatic Diseases | May 04, 2021 Rheumatic/Autoimmune General Allergy/Immunology

Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis

Rheumatology | May 02, 2021 General Allergy/Immunology Gastrointestinal/Hepatic Rheumatic/Autoimmune

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

Rheumatology | May 01, 2021 Nephrology/Urology Rheumatic/Autoimmune General Allergy/Immunology Clinical Pharmacology Diagnostics/Radiology

The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders

Rheumatology | May 01, 2021 General Allergy/Immunology Peds Allergy/Immunology

Novel treatment-refractory preschool wheeze phenotypes identified by cluster analysis of lung lavage constituents

The Journal of Allergy and Clinical Immunology: In Practice | Apr 28, 2021 General Allergy/Immunology Peds Allergy/Immunology

« Prev 1 … 39 40 41 42 43 … 324 Next »

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

Economic burden of patient-reported penicillin allergy prior to total hip and total knee arthroplasty

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: An open‐label study

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

Oral gliadin‐protected superoxide dismutase in addition to phototherapy for treating non‐segmental vitiligo: A 24‐week prospective randomized placebo‐controlled study

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients

Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders

Novel treatment-refractory preschool wheeze phenotypes identified by cluster analysis of lung lavage constituents

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Dupilumab provides favourable long‐term safety and efficacy in children aged ≥ 6 to < 12 years with uncontrolled severe atopic dermatitis: Results from an open‐label phase IIa study and subsequent phase III open‐label extension study

Economic burden of patient-reported penicillin allergy prior to total hip and total knee arthroplasty

Efficacy of maggot debridement therapy on refractory leg ulcers of Behçet disease: An open‐label study

Long-term follow-up and optimization of infliximab in refractory uveitis due to Behcet disease: National study of 103 white patients

Oral gliadin‐protected superoxide dismutase in addition to phototherapy for treating non‐segmental vitiligo: A 24‐week prospective randomized placebo‐controlled study

Anticardiolipin and other antiphospholipid antibodies in critically ill COVID-19 positive and negative patients

Autoantibody predictors of gastrointestinal symptoms in systemic sclerosis

Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis

The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders

Novel treatment-refractory preschool wheeze phenotypes identified by cluster analysis of lung lavage constituents

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic